Cited by 618Receptor Mechanisms and SignalingCardiac Fibrosis and RemodelingCardiomyopathy and Myosin Studies

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha-1 adrenergic response

Open access

Simpson, P·1983·Journal of Clinical Investigation

Open this paper in CoChat — free account Open PDF

Abstract

We have shown recently that norepinephrine stimulates muscle cell hypertrophy in primary cultures from the neonatal rat ventricle and that this stimulation is not blocked by the beta adrenergic antagonist propranolol. The present study was done to define the adrenergic specificity of the myocyte hypertrophic response to norepinephrine. 90% pure, single-cell cultures of nongrowing myocytes were maintained in serum-free medium 199 with transferin and insulin. Myocyte size was quantitated 48 h after addition of adrenergic agents, by measuring cell volume, cell surface area, and cell protein. L-norepinephrine increased myocyte size to a maximum 150% of control; half-maximum effect was obtained at a concentration of 0.2 microM. This increase in cell size was inhibited by the nonselective alpha adrenergic antagonist phentolamine and by the alpha 1 adrenergic antagonists prazosin and terazosin; it was not inhibited by propranolol or by the alpha 2 adrenergic antagonist yohimbine. The beta adrenergic agonist isoproterenol did not increase cell size. Thus, norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci111023

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Biostatistical Analysis.
Feinleib, M., & Zar, J. H. (1975) · Journal of the American Statistical Association · doi:10.2307/2285423 · Cited by 12,671
Biostatistical analysis
Zar, J. H. (1996) · Cited by 7,837
Presynaptic regulation of the release of catecholamines.
Langer, S. Z. (1980) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06843-7 · Cited by 1,504
Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Cross-striations, ultrastructure, and chronotropic response to isoproterenol.
Simpson, P., & Savion, S. (1982) · Circulation Research · doi:10.1161/01.res.50.1.101 · Cited by 453
Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines.
Simpson, P. C., McGrath, A., & Savion, S. (1982) · Circulation Research · doi:10.1161/01.res.51.6.787 · Cited by 429
Studies on isoproterenol-induced cardiomegaly in rats
Stanton, H. C., Brenner, G., & Mayfield, E. D. (1969) · American Heart Journal · doi:10.1016/0002-8703(69)90131-8 · Cited by 216
Cardiac Sympathetic Nerves as the Final Common Pathway in the Induction of Adaptive Cardiac Hypertrophy
Östman‐Smith, I. (1981) · Clinical Science · doi:10.1042/cs0610265 · Cited by 182
Adrenergic antagonists, and a possible link between the increase in cyclic adenosine 3′,5′‐monophosphate and DNA synthesis during liver regeneration
MacManus, J. P., Braceland, B., Youdale, T., & Whitfield, J. F. (1973) · Journal of Cellular Physiology · doi:10.1002/jcp.1040820204 · Cited by 144
Function of myocardial α-adrenoceptors
Benfey, B. G. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90062-v · Cited by 122

Show all 20 references

Research works printed but not linked: 1

Kyncl, J. J., E. N. Bush, and S. A. Buckner. 1982. Alpha adrenergic blocking properties of terazosin. Fed. Proc. 41:1648.

Sorted by citations

Items 401–500 of 618

Transition from Hypertrophy to Failure—Β-Adrenergic Desensitization of the Heart
Böhm, M., Kouchi, I., Schnabel, P., & Zolk, O. (1999) · Heart Failure Reviews · doi:10.1023/a:1009851619173 · Cited by 10
Hypertension and Left Ventricular Hypertrophy: Is Drug Therapy Beneficial?
Eselin, J. A., & Carter, B. L. (1994) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1994.tb02790.x · Cited by 10
Common Pathways for Primary Hypertrophic and Dilated Cardiomyopathy
Kroumpouzou, E., Gomatos, I. P., Kataki, A., Karayannis, M. K., Dangas, G., & TOUTOUZAS, P. K. (2003) · Hybridoma and Hybridomics · doi:10.1089/153685903321538071 · Cited by 10
Indirect inhibition of myocyte RNA and protein synthesis by interleukin-1
Hosenpud, J. D. (1990) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(90)91117-p · Cited by 10
Congestive heart failure in the elderly
Rengo, F., Acanfora, D., Trojano, L., Furgi, G., Picone, C., Iannuzzi, G. L., Vitale, D. F., Rengo, C., Ferrara, N., & CHF Italian Study Investigators (1996) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(96)00734-0 · Cited by 10
Regression of left ventricular mass in systemic hypertension
Georgiou, D., & Brundage, B. H. (1992) · Clinical Cardiology · doi:10.1002/clc.4960150104 · Cited by 10
Effects of norepinephrine on neonatal rat cardiocyte growth and differentiation
Marino, T. A., Walter, R. A., Cobb, E. A., Palasiuk, M., Parsons, T., & Mercer, E. (1990) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02624452 · Cited by 10
Cardiovascular and Sympathetic Nervous Response to Dynamic Exercise in Patients with Essential Hypertension.
Saitoh, M., Miyakoda, H., Kitamura, H., Kinugawa, T., Hisatome, I., Kotake, H., & Mashiba, H. (1992) · Internal Medicine · doi:10.2169/internalmedicine.31.606 · Cited by 10
Effects of antihypertensive treatment on cardiac IGF-1 during prevention of ventricular hypertrophy in the rat
Jalil, J., Ebensperger, R., Meléndez, J., Acevedo, E., Sapag-Hagar, M., González-Jara, F., Galvez, A. S., Pérez-Montes, V., & Lavandero, S. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00097-1 · Cited by 10
Cardiac pathophysiology and its heterogeneity in patients with established hypertensive disease
Laragh, J. H. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90199-4 · Cited by 10
Are different hemodynamic patterns of antihypertensive drugs clinically important?
Julius, S. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf01409481 · Cited by 10
Application of high resolution two‐dimensional polyacrylamide gel electrophoresis of polypeptides from cultured neonatal rat cardiomyocytes: Regulation of protein synthesis by catecholamines
He, C., Müller, U., OBERTHÜR, W., & Werdan, K. (1992) · Electrophoresis · doi:10.1002/elps.11501301163 · Cited by 10
Plasma Neprilysin Displays No Relevant Association With Neurohumoral Activation in Chronic HFrEF
Prausmüller, S., Arfsten, H., Spinka, G., Freitag, C., Bartko, P. E., Goliasch, G., Strunk, G., Pávó, N., & Hülsmann, M. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015071 · Cited by 9
Angiotensin converting enzyme inhibition for cardiac hypertrophy in patients with end‐stage renal disease: What is the evidence?
Wang, A. Y.-M., Li, P. K., Lui, S., & Sanderson, J. E. (2004) · Nephrology · doi:10.1111/j.1440-1797.2004.00260.x · Cited by 9
Cardiovascular Catecholamine Receptors in Children: Their Significance in Cardiac Disease
Buijs, E. A. B., Danser, A. H. J., Meijer, N. I., & Tibboel, D. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31822233dd · Cited by 9
Carbon monoxide-induced cardiac hypertrophy is not reduced by alpha- or beta-blockade in the rat
Penney, D. G., & Formolo, J. M. (1993) · Toxicology · doi:10.1016/0300-483x(93)90179-v · Cited by 9
Myocardial contractility and ventricular myosin isoenzymes as influenced by cardiac hypertrophy and its regression
Tanamura, A., Takeda, N., Iwai, T., Tuchiya, M., Arino, T., & Nagano, M. (1993) · Basic Research in Cardiology · doi:10.1007/bf00788532 · Cited by 9
Cardiac sympathetic activity in the asymmetrically hypertrophied septum in patients with hypertension or hypertrophic cardiomyopathy
Shimizu, M., Ino, H., Okeie, K., Emoto, Y., Yamaguchi, M., Yasuda, T., Fujino, N., Fujii, H., Fujita, S., Mabuchi, H., et al. (2000) · Clinical Cardiology · doi:10.1002/clc.4960230512 · Cited by 9
G protein‐coupled receptor signalling in in vivo cardiac overload
Rapacciuolo, A., Esposito, G., Prasad, S. V. N., & Rockman, H. A. (2001) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2001.00884.x · Cited by 9
Myocardial Cellular Development and Morphogenesis
Zhu, H. (1997) · Elsevier eBooks · doi:10.1016/b978-012436570-4/50004-2 · Cited by 9
Molecular mechanisms of cardiac gene expression
Nadal‐Ginard, B., & Mahdavi, V. (1993) · Steinkopff eBooks · doi:10.1007/978-3-642-72497-8_5 · Cited by 9
Regulation of protein biosynthesis in neonatal rat cardiomyocytes by adrenoceptor‐stimulation: Investigations with high resolution two‐dimensional polyacrylamide gel electrophoresis
He, C., Müller, U., & Werdan, K. (1992) · Electrophoresis · doi:10.1002/elps.11501301164 · Cited by 9
Bone Marrow–Derived Regenerated Cardiomyocytes (CMG Cells) Express Functional Adrenergic and Muscarinic Receptors
Hakuno, D., Fukuda, K., Makino, S., Konishi, F., Tomita, Y., Manabe, T., Suzuki, Y., Umezawa, A., & Ogawa, S. (2002) · Circulation · doi:10.1161/hc0302.102593 · Cited by 8
Expanding Role of β‐Blockade in the Management of Chronic Heart Failure
Patterson, J. H., & Rodgers, J. E. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.4.451.32116 · Cited by 8
Inhibition of angiotensin II Gq signaling augments β-adrenergic receptor mediated effects in a renal artery stenosis model of high blood pressure
Harris, D. M., Chen, X., Pesant, S., Cohn, H. I., MacDonnell, S. M., Boucher, M., Vinge, L. E., Raake, P. W. J., Moraca, S. R., Li, D., et al. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.09.708 · Cited by 8
Methoxamine Inhibits Transient Outward Potassium Current Through α1A-Adrenoceptors in Rat Ventricular Myocytes
Martínez, M. L., & Delgado, C. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200002000-00006 · Cited by 8
Preclinical cardiac involvement in phaeochromocytoma: a study with integrated backscatter
Galetta, F., Bernini, G. P., Franzoni, F., Tocchini, L., Taurino, C., Bardini, M., Rossi, M., Salvetti, A., & Santoro, G. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03127.x · Cited by 8
Carteolol, an Antihypertensive β-Blocker with Intrinsic Sympathomimetic Activity, Reduces ECG Evidence of Left Ventricular Hypertrophy
Rosales, O. R., Sander, G. E., Roffidal, L. E., Given, M. B., & Giles, T. D. (1989) · CHEST Journal · doi:10.1378/chest.95.1.43 · Cited by 8
Induction of c-fos mRNA Expression by Pure Pressure Overload in Cultured Cardiac Myocytes
Sakai, H., Urasawa, K., Oyama, N., Kaneta, S., Saito, T., Kitabatake, A., & Tsutsui, H. (2007) · International Heart Journal · doi:10.1536/ihj.48.359 · Cited by 8
Efficacy of vasodilators in the treatment of heart failure
Cohn, J. N. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90477-i · Cited by 8
Suppression of ethanol-induced cardiac hypertrophy by β-adrenoceptor blockade
King, D. (1990) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(90)90954-z · Cited by 8
Effects of chronic infusion of norepinephrine on cardiac structure, function, and biochemistry: Physiologic versus pathologic hypertrophy
Laks, M. M. (2009) · Clinical Cardiology · doi:10.1002/clc.4960121311 · Cited by 8
Docosahexaenoic acid inhibits protein kinase C translocation/activation and cardiac hypertrophy in rat cardiomyocytes
Castillo, A., Ruzmetov, N., & Harvey, K. A. (2005) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000006 · Cited by 8
Guanabenz Combination Therapy Inhibits Sympathetic Nerve Activity and Regresses Left Ventricular Hypertrophy
Miyajima, E., Shigemasa, T., Endo, T., Hishiki, S., & Kawano, Y. (2000) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007895222149 · Cited by 8
MEDICAL THERAPY OF CHRONIC HEART FAILURE
Eichhorn, E. J. (1998) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70046-1 · Cited by 8
α-Adrenergic Signal Transduction in Renin Transgenic Rats
Schnabel, P., Nohr, T., Nickenig, G., Paul, M., & Böhm, M. (1997) · Hypertension · doi:10.1161/01.hyp.30.6.1356 · Cited by 8
Reduction by β‐adrenoceptor blockade of hypoxia‐induced right heart hypertrophy in the rat
Östman‐Smith, I. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb17229.x · Cited by 8
Alterations of Cardiac α- and β-Adrenoceptors and Inotropic Responsiveness in Hypertensive Transgenic Rats Harbouring the Mouse Renin Gene (TGR(mREN2)27)
Tawfik-Schlieper, H., Moll, M., Schmid, B., Schwinger, R. H. G., Paul, M., Ganten, D., & Böhm, M. (1995) · Clinical and Experimental Hypertension · doi:10.3109/10641969509037413 · Cited by 8
The role of the adrenergic system in the heart: Regulation of contractility by cardiac adrenoceptors
Ledda, F., Amerini, S., Rubino, A., & Mantelli, L. (1991) · Pharmacological Research · doi:10.1016/1043-6618(91)90117-g · Cited by 8
Molecular biology of oncogenes and cardiovascular hypertrophy
Neyses, L., Grohé, C., & Vetter, H. (1996) · Springer eBooks · doi:10.1007/978-94-009-0083-7_11 · Cited by 8
Role of adrenergic receptor systems in canine left ventricular hypertrophy
Chiba, M. (1989) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(89)90770-0 · Cited by 8
Comments on "Load regulation of the properties of adult feline cardiocytes: the role of substrate adhesion."Circ Res 1986;58:692-705.
Simpson, P. C. (1988) · Circulation Research · doi:10.1161/01.res.62.4.864 · Cited by 7
The α1-Adrenergic Receptors
Simpson, P. C. (2006) · Humana Press eBooks · doi:10.1385/1-59259-931-1:207 · Cited by 7
Left ventricular dilatation and failure post-myocardial infarction: Pathophysiology and possible pharmacologic interventions
Firth, B. G., & Dunnmon, P. M. (1990) · Cardiovascular Drugs and Therapy · doi:10.1007/bf02018264 · Cited by 7
Selective Cardiac Neuroadrenergic Abnormalities in Hypertensive Patients with Left Ventricular Hypertrophy
Giordano, A., Melina, G., Calcagni, M. L., Schinzari, F., Cirillo, F., Mettimano, M., Cardillo, C., & Melina, D. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.01.009 · Cited by 7
Involvement of Protein Kinase A and C in Norepinephrine- and Angiotensin II-Induced Modulation of Cardiac IKs
Si, M., Xu, J., Zhang, F., Wang, C., Du, X., & Zhang, H. (2013) · Pharmacology · doi:10.1159/000354881 · Cited by 7
Carvedilol in the treatment of chronic heart failure
Moe, G. W. P. L. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.5.831 · Cited by 7
β-Blocker therapy in heart failure: Pathophysiology and clinical results
Carson, P. E. (1999) · Current Problems in Cardiology · doi:10.1016/s0146-2806(99)90007-5 · Cited by 7
Differential growth of neonatal WKY and SHR ventricular myocytes within sympathetic co-cultures
Atkins, D. L. (1992) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(92)91088-m · Cited by 7
Enhancement of PAI-1 mRNA in cardiovascular cells after kainate injection is mediated through the sympathetic nervous system
Miskin, R., & Abramovitz, R. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.02.016 · Cited by 7
AUGMENTED EXERCISE PLASMA NORADRENALINE WITH IMPAIRED CHRONOTROPIC RESPONSIVENESS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY*
Omodani, H., Kinugawa, T., Oginö, K., Furuse, Y., Yamaguchi, M., Mori, M., Endo, A., Kato, M., Kato, T., Osaki, S., et al. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.tb02177.x · Cited by 7
Effects of regression of cardiac hypertrophy on myocardial contractility and ventricular myosin isoenzymes
Iwai, T., Takeda, N., Tuchiya, M., Arino, T., Tanamura, A., & Nagano, M. (1992) · Molecular and Cellular Biochemistry · doi:10.1007/bf00249699 · Cited by 7
Can hypertension be prevented? The Danish Hypertension Prevention Project and the Trial of Prevention of Hypertension studies
Skov, K., Julius, S., Nesbitt, S. D., & Mulvany, M. J. (2002) · Current Opinion in Cardiology · doi:10.1097/00001573-200207000-00010 · Cited by 7
Cardiovascular Function During Development and the Response to Hypoxia
Anderson, P. A. W., Kleinman, C. S., Lister, G., & Talner, N. S. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7216-9654-6.50066-7 · Cited by 7
Risk Reduction Following Regression of Cardiac Hypertrophy
Schmieder, R. E. (1990) · Clinical and Experimental Hypertension · doi:10.3109/10641969009073508 · Cited by 7
Effects of Captopril or Nitrendipine on Left Ventricular Collagen or Laminin B2 Gene Expression.
Katayama, S., Abe, M., Inaba, M., Itabashi, A., & Ishii, J. (1993) · Japanese Heart Journal · doi:10.1536/ihj.34.773 · Cited by 7
Regulation of expression of contractile proteins with cardiac hypertrophy and failure
Martin, X., Wynne, D. G., Glennon, P. E., Moorman, A. F. M., & Boheler, K. R. (1996) · Molecular and Cellular Biochemistry · doi:10.1007/bf00227897 · Cited by 7
Cooperative action of insulin and catecholamines on stimulation of ornithine decarboxylase activity in neonatal rat heart cells
Roraason, M. (1990) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(90)91007-t · Cited by 7
Neurohormonal connections with mitochondria in cardiomyopathy and other diseases
Dorn, G. W. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00167.2022 · Cited by 6
Study of the Expression Transition of Cardiac Myosin Using Polarization-Dependent SHG Microscopy
Yuan, C., Zhao, X., Wang, Z., Borg, T. K., Ye, T., Khalpey, Z. I., Runyan, R. B., Shao, Y., & Gao, B. Z. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2019.12.030 · Cited by 6
Prevention of Cardiac Hypertrophy by a Sub-Antihypertensive Dose of the .ALPHA.1-Adrenergic Antagonist Bunazosin in Dahl Salt-Sensitive Rats.
Izumi, Y., Matsuoka, M., Kubo, A., Nakayama, T., Fukuda, N., Watanabe, Y., Soma, M., & Kanmatsuse, K. (1996) · Hypertension Research · doi:10.1291/hypres.19.147 · Cited by 6
Southwestern Internal Medicine Conference: The Prevention of Congestive Heart Failure: Left Ventricular Dilation and its Management
Firth, B. G., & Dunnmon, P. M. (1990) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199004000-00010 · Cited by 6
Contribution of both ?- and ?-adrenoceptors to the inotropic effects of catecholamines in the rabbit heart
Jahnel, U., Kaufmann, B., Rombusch, M., & Nawrath, H. (1992) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168740 · Cited by 6
Effect of left ventricular pressure and volume overload on α-adrenoceptor activity in patients with rheumatic heart valvular disease
Dzimiri, N., Moorji, A., Kumar, M., Bakr, S., Kumar, N., Almotrefi, A. A., & Halees, Z. Y. A. (1996) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(95)02030-6 · Cited by 6
Cardiac alpha-receptors and cardiac hypertrophy in genetic predisposition to hypertension
Böhm, M., Mende, U., Schmitz, W. L., & Scholz, H. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90392-3 · Cited by 6
How can we block sympathetic overactivity? Effects of rilmenidine and atenolol in overweight hypertensive patients
Конради, А. О., Kasherininov, Y. R., Анатольевич, Ш. А., Курбановна, Ш. Е., Vachrameeva, N. V., Крутиков, А. Н., Смирнова, Е. В., & Shlyakhto, E. V. (2006) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002004 · Cited by 6
Transcriptional regulation of alpha-1 adrenergic receptors
Schwinn, D. A. (1998) · Frontiers in bioscience · doi:10.2741/a279 · Cited by 6
Neurohormones, Cytokines and Programmed Cell Death in Heart Failure: A New Paradigm for the Remodeling Heart
Valgimigli, M., Curello, S., Ceconi, C., Agnoletti, L., Comini, L., Bachetti, T., Merli, E., & Ferrari, R. (2001) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1013771805743 · Cited by 6
Evidence of myocyte hyperplasia in hypertrophic cardiomyopathy and other disorders with myocardial hypertrophy?
Ferrans, V. J., & Rodriguez, E. (1988) · Steinkopff eBooks · doi:10.1007/978-3-642-85369-2_4 · Cited by 6
Regulation of Rat Cardiac Myocyte Growth by a Neuronal Factor Secreted by PC12 Cells
Atkins, D. L., Krumm, P. A., Schutte, B. C., Harrison, J. D., & Green, S. H. (1997) · Pediatric Research · doi:10.1203/00006450-199706000-00007 · Cited by 6
ANGIOTENSIN II RECEPTORS IN CARDIAC LEFT VENTRICLES OF DAHL RATS
Sumida, Y., Umemura, S., KOBAYASHI, S., Kihara, M., Tamura, K., Ishigami, T., Ochiai, H., Chiba, E., Nyui, N., & Ishii, M. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.t01-16-.x · Cited by 6
Differential Effects of Amiloride on the Basal Rate and the Pressure Overload-induced Increase in Protein Synthesis in Perfused Rat Heart
Fukuzawa, J., Osaki, J., & Haneda, T. (1994) · Clinical and Experimental Hypertension · doi:10.3109/10641969409078029 · Cited by 6
New concepts regarding events that lead to end-stage heart disease
Cohn, J. N. (1995) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00877859 · Cited by 6
Effects of Bunazosin, a Selective α1-Adrenergic Blocking Agent, on Myocardial Energy Metabolism in Ischemic Dog Heart
Yoshida, R., Ichihara, K., & Abiko, Y. (1990) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.53.435 · Cited by 6
Beta Blockers in Heart Failure: Issues in Management of Individual Patients
Metra, M., Nodari, S., D’Aloia, A., Cagnazzi, E., Fiorina, C., Verde, S. F., & Cas, L. D. (1999) · Heart Failure Reviews · doi:10.1023/a:1009807918615 · Cited by 6
Myocardial Growth and the Development and Regression of Increased Ventricular Mass
Perloff, J. K. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5894-6.50027-7 · Cited by 5
Transgenic models of myocardial dysfunction
Bernard Swynghedauw, A. (1997) · Heart Failure Reviews · doi:10.1007/bf00127409 · Cited by 5
Left ventricular hypertrophy reversal with labetalol and propranolol: A prospective, randomized, double-blind study
Szlachcic, J., Hall, W. D., Tubau, J. F., Porter, V. D., Vollmer, C., Wollam, G. L., Hirsch, A. T., & Massie, B. M. (1990) · Cardiovascular Drugs and Therapy · doi:10.1007/bf01857749 · Cited by 5
Stress Kinase Signaling in Cardiac Myocytes
Ai, X., Yan, J., & Bare, D. J. (2022) · Springer eBooks · doi:10.1007/978-3-031-08309-9_3 · Cited by 5
Evidence for cardiovascular remodeling in a patient with Bartter's syndrome
Schmitz, U., Ko, Y., Becher, H. H., Ludwig, M. Z., Vetter, H., & D�sing, R. (1994) · Journal of Molecular Medicine · doi:10.1007/bf00190744 · Cited by 5
Control of myocardial tissue components and cardiocyte organelles in pressure‐overload hypertrophy of the cat right ventricle
Lauva, I. K., Brody, E. A., Tiger, E., Kent, R. L., Cooper, G., & Marino, T. A. (1986) · American Journal of Anatomy · doi:10.1002/aja.1001770109 · Cited by 5
Effect of insulin-induced hypokalemia on lumbar sympathetic nerve activity in anesthetized rats
Muntzel, M. S., Joseph, T., & Onwumere, O. (2004) · Journal of Hypertension · doi:10.1097/00004872-200409000-00020 · Cited by 5
SYMPATHETIC OVERACTIVITY AND CORONARY RISK IN HYPERTENSION
Amerena, J. V., & Julius, S. (1997) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1997.tb00882.x · Cited by 5
Adrenergic receptor coupling and uncoupling in heart failure
Port, J. D., & Bristow, M. R. (2005) · CRC Press eBooks · doi:10.3109/9780203503249-23 · Cited by 5
Long-term treatment in arterial hypertension for protecting hypertrophic myocardium
Vogt, M., Motz, W., & Strauer, B. E. (1991) · Steinkopff eBooks · doi:10.1007/978-3-662-30769-4_22 · Cited by 5
Cardiac Mechanical Dysfunction Induced by Ischemia‐reperfusion in Perfused Heart Isolated from Stroke‐prone Spontaneously Hypertensive Rats
Itoh, T., Abe, K., Tokumura, M., Hirono, S., Haruna, M., & Ibii, N. (2004) · Clinical and Experimental Hypertension · doi:10.1081/ceh-200031822 · Cited by 5
SERCA2 and ANF Promoter-Activity Studies in Hypertrophic Cardiomyocytes Using Liposome-, Gene Gun-, and Adenovirus-Mediated Gene Transfer
Eizema, K., Heugten, H. A. A. V., Bezstarosti, K., Setten, M. C. V., Schneider-Rasp, S., Poller, W. C., & Lamers, J. M. J. (2000) · Progress in experimental cardiology · doi:10.1007/978-1-4615-4423-4_5 · Cited by 5
The Dilemma of Mild Hypertension
Drayer, J. I. M. (1985) · CHEST Journal · doi:10.1378/chest.88.3_supplement.183s · Cited by 5
Long-term .ALPHA.1 blockade does not reverse cardiac hypertrophy in spontaneously hypertensive rats.
Nishimura, H., Kubota, J., Okabe, M., Ueyama, M., OKA, T., & KAWAMURA, K. (1993) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.57.898 · Cited by 5
α1-Adrenergic receptors in cardiac ventricles of dahl rats
Hayashi, S., Umemura, S., 芦野, 和., Hirawa, N., Toya, Y., Abe, Y., & Ishii, M. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00142-c · Cited by 5
Hypertonie und Herz
Strauer, B. E., & Motz, W. (1988) · Springer eBooks · doi:10.1007/978-3-662-39609-4_37 · Cited by 5
TAK733 attenuates adrenergic receptor-mediated cardiomyocyte hypertrophy via inhibiting ErkThr188 phosphorylation
Lee, C. Y., Lee, J., Seo, H., Shin, S., Kim, S. W., Lee, S., Lim, S., & Hwang, K. (2019) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-180476 · Cited by 4
Regulation of human cardiac myosin heavy chain genes: The effect of catecholamine
Chen, J. J., Wang, D. L., Shih, N. L., Hsu, K.-H., Lien, W. P., & Liew, C. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91090-d · Cited by 4
Signal Transduction of Cardiac Myocyte Hypertrophy
Aoki, H., & Izumo, S. (2001) · Elsevier eBooks · doi:10.1016/b978-012656975-9/50060-2 · Cited by 4
Hypertrophic stimuli augment expression of cMG1/ERF‐1, a putative zinc‐finger motif transcription factor, in rat cardiomyocytes
Manabe, T., Fukuda, K., Pan, J., Nagasaki, K., Yamaguchi, K., & Ogawa, S. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01601-4 · Cited by 4
Antihypertensive Drugs Reduce Noradrenaline-induced Hypertrophy of Cultured Myocardial Cells
Lähteenmäki, T. A., Sievi, E., & Vapaatalo, H. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb05926.x · Cited by 4
Molecular and Cellular Events in Myocardial Hypertrophy and Failure
Sawyer, D. B., & Colucci, W. S. (2002) · doi:10.1007/978-1-4615-6490-4_4 · Cited by 4
Control of Growth in Neonatal Pig Hearts
Beinlich, C. J., & Morgan, H. E. (1993) · Springer eBooks · doi:10.1007/978-1-4615-3078-7_1 · Cited by 4
Pathophysiology of Cardiovascular Structural Changes in Hypertension
Jern, S. (1992) · Clinical and Experimental Hypertension · doi:10.3109/10641969209036179 · Cited by 4
Enalapril reduces the enhanced 1,2-diacylglycerol content and RNA synthesis in spontaneously hypertensive rat hearts before established hypertension
Okumura, K., Kondo, J., Yoshino, M., Ishikawa, K., Asano, H., Hashimoto, H., & Ito, T. (1992) · Molecular and Cellular Biochemistry · doi:10.1007/bf00229638 · Cited by 4

Authors: Simpson, P.
Affiliations: San Francisco VA Medical Center (US)
Corresponding author: Simpson, P
ORCID: Simpson, P
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 1983-08-01
Volume: 72
Issue: 2
Pages: 732-738
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci111023
PMC: PMC1129233
OpenAlex: W2110889457
Cited by: 618
References: 20
Citations by year: 2026: 4 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 6 · 2021: 5 · 2020: 5 · 2019: 7 · 2018: 3 · 2017: 4 · 2016: 5 · 2015: 5 · 2014: 3 · 2013: 10 · 2012: 6
FWCI: 3.65
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: University of California, San Francisco
National Heart, Lung, and Blood Institute (R01HL031113)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Keywords: norepinephrine, cardiac hypertrophy, alpha1-adrenoceptors, alpha-blockers, phentolamine, prazosin, terazosin, yohimbine, isoproterenol, propranolol
MeSH terms: Adrenergic alpha-Antagonists, Animals, Cardiomegaly, Isoproterenol, Myocardium, Norepinephrine, Phentolamine, Prazosin, Propranolol, Receptors, Adrenergic, Receptors, Adrenergic, alpha, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha-1 adrenergic response

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks